NCT01398241View on ClinicalTrials.gov

A Study of RO5267683 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Healthy Volunteer
Interventions
DRUG

RO5267683

Multiple ascending doses

DRUG

placebo

Multiple ascending doses

Trial Locations (1)

67064

Strasbourg

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01398241 - A Study of RO5267683 in Healthy Subjects | Biotech Hunter | Biotech Hunter